CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue:
Total revenue	$ 2,268,396	$ 2,049,107
Cost of revenue:
Total cost of revenue	375,317	415,268
Gross profit	1,893,079	1,633,839
Operating expenses:
Research and development costs	618,527	705,981
Selling and marketing	802,566	1,189,846
General and administrative	892,654	849,939
Restructuring costs	0	744
Total operating expenses	2,313,747	2,746,510
Operating income (loss)	(420,668)	(1,112,671)
Interest and other expense	(79,863)	(117,995)
Income (loss) before income taxes	(500,531)	(1,230,666)
Income tax expense (benefit)	(52,761)	(121,260)
Net income (loss)	(447,770)	(1,109,406)
Less: Accrual of Series A redeemable convertible preferred stock dividends	315,215	300,921
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	9,851	14,815
Net income (loss) attributable to common stockholders	$ (772,836)	$ (1,425,142)
Basic net income (loss) per share attributable to common stockholders	$ (0.11)	$ (0.20)
Diluted net income (loss) per share attributable to common stockholders	$ (0.11)	$ (0.20)
Weighted average basic shares outstanding	7,119,735	7,082,276
Weighted average diluted shares outstanding	7,119,735	7,082,276
Product Revenue
Revenue:
Total revenue	$ 1,022,186	$ 594,928
Cost of revenue:
Total cost of revenue	34,129	20,719
Support and Services Revenue
Revenue:
Total revenue	1,246,210	1,454,179
Cost of revenue:
Total cost of revenue	$ 341,188	$ 394,549